Showing results (461-470 of 572) with videos related to

Sort By:
Pageof 58
Clinical Endocrinology|December 1, 1986
Effects of somatostatin analogue SMS 201-995 in non-insulin-dependent diabetesR R Davies, M Miller, S J Turner, et al.
Lancet (London, England)|January 31, 1976
Failure of somatostatin to correct manifest diabetic ketoacidosisK Lundbaek, A P Hansen, H Orskov, et al.
Clinical Endocrinology|July 1, 1983
Evidence that thyroid hormones regulate gluconeogenesis from glycerol in manA J McCulloch, D G Johnston, P H Baylis, et al.
Diabetes Research and Clinical Practice|February 1, 1992
The ketosis-resistance in fibro-calculous-pancreatic-diabetes. 1. Clinical observations and endocrine-metabolic measurements during oral glucose tolerance testC S Yajnik, K M Shelgikar, S S Naik, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1992
The effects of human proinsulin on glucose turnover and intermediary metabolism in insulin-dependent-diabetes mellitusS N Davis, M Ansiferov, C Hetherington, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2000
Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolismH Nørrelund, N Vahl, A Juul, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|April 1, 1991
No deterioration of oral glucose tolerance during pregnancy in rural TanzaniaA B Swai, H M Kitange, D G McLarty, et al.
Clinical Endocrinology|April 1, 1983
Insulin sensitivity in hyperthyroidism: measurement by the glucose clamp techniqueA J McCulloch, P D Home, R Heine, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1996
Acute effects of the human amylin analog AC137 on basal and insulin-stimulated euglycemic and hypoglycemic fuel metabolism in patients with insulin-dependent diabetes mellitusB Nyholm, N Møller, C H Gravholt, et al.
Metabolism: Clinical and Experimental|July 1, 1988
Glucagon responses to intravenous arginine and oral glucose in insulin-dependent diabetic patients during six months conventional or continuous subcutaneous insulin infusionK Hermansen, O Schmitz, N Boye, et al.
Pageof 58